Home|News|Factoring: the most cost-effective and efficient solution for financing a company's growth under LBO
Factoring: the most cost-effective and efficient solution for financing a company's growth under LBO
Romain Chaufour, Development Director at Fibus, France's leading factoring advisory firm, urges investors to consider factoring early on to optimise the financing of their future investments. Read his interview in Le Figaro Partner.
What is the relevance of factoring for companies under LBO?
Romain Chaufour: Factoring is the most cost-effective and efficient short-term financing technique available for supporting the organic or external growth of a company, especially under LBO. It represents the largest source of liquidity available to a B2B company, generally equivalent to about two months of revenue. At Fibus, four out of five operations are dedicated to LBO companies, both in France and internationally - we currently operate in 37 countries.
What makes Fibus's support unique?
R.C.: Our uniqueness lies in our involvement with the fund from the moment the acquisition is contemplated, well before the factoring programme itself is set up. We assess the relevance of factoring as a financing source for the investment in terms of the amounts financed, the timing of implementation, and the internal organisation. Thus, before making its move, the fund knows the amount of financing it can count on, the market's appetite, the cost of the factoring programme, and the level of support the teams will need during its implementation.
What is the added value for the investment fund?
R.C.: By being aware of these various elements, the fund has all the necessary information to start the client accounts financing project at the stage that suits it best: either quickly after the acquisition to secure the operation; or at a later time when it is necessary to finance the organic growth of the company under LBO and/or carry out external growth operations; or to refinance part of the acquisition debt or the RCF.
Which specific tools do you rely on?
R.C.: We have developed ARI, a range of software without equal on the market. It allows for the management and optimisation of factoring programmes, regardless of the number of legal entities involved, clients, or currencies. We are the only ones who can do this. With ARI, CFOs have a management tool for their factoring programme that maximises available financing and improves the functioning of their programmes: it's also a considerable time saver.
Is the volume of deals in private equity on the rise again?
R.C.: The private equity market will still be nuanced in 2024. That's why we are highly sought after by funds to audit their existing investment portfolios: to optimise their working capital requirements, identify new sources of financing, or renegotiate existing programmes... Experience shows us that there are always improvements to be made.
These articles may interest you
How to choose the right factoring solution ?
Traditional or fintech, standard or tailored… here are some key insights to help you navigate a vast array of options. Read the article from Le Nouvel Économiste for a clearer understanding of the different factoring financing solutions available.
New signings of Fibus in September 2024
5 cases among our latest signings achieved in Factoring, Trade and Digital, in France and international, for ETI and big groups. The business sectors for these signings : manufacture, wholesale, telecommunications and treatment and disposal of non-hazardous waste.
Fibus' expertise covers 100% of factoring needs, including credit insurance and digital solutions for monitoring programmes.
Fibus' expertise covers 100% of factoring needs, including credit insurance and digital solutions for monitoring programmes.
New signings of Fibus in July 2024
Fibus met their different requirements - Factoring, Trade credit and IT solutions in various contexts: strengthening cash flow position, supporting an international build-up strategy, optimizing funding for a fast growing group in Europe.
Industries: Regulatory and pharmaceutical advisory services, Manufacture of pharmaceutical preparations, Manufacture of metal structures and parts of structures.
Industries: Regulatory and pharmaceutical advisory services, Manufacture of pharmaceutical preparations, Manufacture of metal structures and parts of structures.
Contact us, so that, together, we can find the best solution for financing your accounts receivable.
Write us